Finished Dosage Forms (Products)

Finished Dosage Forms (Products) Companies (200)

Finished Dosage Forms (Products) News

Finished Dosage Forms (Products) Products (200)

  • Product Nerviplex

    Nerviplex is nucleotide based food supplements, with high concentration of nucleotides of pyrimidine bases and vitamins indicated for treatment of peripheral neuropathies. Nucleotides act directly by regenerating damaged nerves, improving myelin sheath regeneration, increasing motor neuron conduction and a...
  • Product Gyno-Balance - pH regulator

    Non – hormonal vaginal gel specially formulated to restore physiological vaginal pH and balance its bacterial flora.
    Indicated in case of bacterial vaginosis, vaginitis and vaginal mycosis. It prevents relapses, especially following antibiotics treatments. The vaginal pH is an important factor f...
  • Product Propofol MCT/LCT Injection & Propofol Injection

    Strengths: 10 mg/ml (1% w/v) & 20 mg/ml (2% w/v)
    Indication:  For induction & maintenance of anesthesia      Propofol MCT Injection: 10 mg/ml - Available as 20 ml Ampoule, 20 ml Vial, 50 ml Vial, 100 ml Vial & 20 mg/ml - Available as 20 ml Vial
    Propofol Injection -&...
  • Product Aciclovir 800 mg, 400 mg, 200 mg, Liposomal gel, Cream, Suspension

    Type: OTC,  Rx
    Pharmaceutical form: Tablets, Liposomal topical Gel, Cream, Suspension

    Active substance: Aciclovirum

    ...
  • Product LYOINREADY® High Efficiency Freeze Drying Guard

    LyoInReady® High efficiency Freeze-drying Guard tray is a ready-to-use freeze drying tray with a unique design to make lyophilization processes easier and more efficient, with better yield. It can significantly reduce operation time and complications, as well as contamination risk, while optimizing process...
  • Product Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL)

    Enoxaparin injection is an anticoagulant primarily indicated for the prevention of deep vein thrombosis (DVT), which can lead to life-threatening pulmonary embolisms (blood clots in the lungs).
  • Product Liposomal Amphotericn B Injection

    Anti-fungal polyene antibiotics produced from a strain of Streptomyces nodosus
  • Product Pharmaceutical Services

    Midas Pharma offers services over the entire pharmaceutical value chain — from the synthesis of Drug Substances to the registration of Finished Drug Products. Our in-house specialist teams combined with a diverse network of partners enable us to draw upon the knowledge, people and resources to meet our cus...
  • Product Brevicillin® Drops

    Brevicillin® Drops is a probiotic food supplement designed to support the balance of the gut microbiota during treatment with Amoxicillin or Amoxicillin/Clavulanic Acid, with an easy-to-administer formulation suitable for children, including infants.

    It contains Bifidobacterium breve PRL2020, ...
  • Product Aromatherapy: decongestant nasal spray

    Laboratoires Gilbert is specialized in Aromatherapy.Breathing decongestant nasal spray is a 2 in 1 product : winter diseases + Allergy season.Recognized anti-inflammatory action in allergic rhinitis
    Reduces swelling of the mucous membrane
    Decreases inflammation
    Instant cooling effect 
    ...
  • Product Lozenges - Flurbiprofen

    • Active ingredient (s): 8.75 mg Flurbiprofen Flurbiprofen belongs to the group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) which are used to relive pain and inflammation. Flurbiprofen lozenges are used to reliev a painful or swollen sore throat. • Flavours (2): Mint  •...
  • Product Diclofenac Epolamine Medicated Plaster

    MIAT has developed and registered (Hybrid legal basis) in some European countries a medicated plaster based on Diclofenc Epolamine for the symptomatic local treatment of pain and inflammation of rheumatic or traumatic nature of joints, muscles, tendons and ligaments. The product is available only through i...
  • Product L-Carnitine Oral Solution 3g/10ml (30%) Pediatric

    Therapeutic indications

    Levocarnitine Pediatric 30% Oral Solution is indicated for the treatment of primary and secondary carnitine deficiency in children of under 12 years, infants and newborns.
    L-carnitine belongs to the substances that act in the body for the smooth progressio...
  • Product LYMECYCLINE

    Lymecycline is a second-generation oral tetracycline prodrug known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It is widely used in the treatment of acne and other susceptible bacterial infections, particularly where good tolerability is essential.
  • Product Azacitidine Seacross 25mg/ml Powder for suspension for injection

    Therapeutic indications:Azacitidine Seacross is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:

    •intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System ...
  • Product MEDITOP Pharmaceutical Ltd's Portfolio

    Please find enclosed product list.
  • Product Dimenhydrinate

    - Active substance(s): Dimenhydrinate
    - Pharmaceutical form(s): Tablets
    - Strength(s):  50 mg 
  • Product THYROFIX (Levothyroxine Sodium)

    INDICATIONS: Hypothyroidism.

    FORMS & PACKAGING:

    13 mcg Levothyroxine Sodium /tablet (BT x 30 tablets)


    25 mcg Levothyroxine Sodium /tablet (BT x 30 tablets)


    50 mcg Levothyroxine Sodium /tablet (BT x 30 tablets)


    62 mcg Levothyroxine Sodiu...
Find your finished dosage forms suppliers online: our directory lists nearly 500 suppliers offering 2,500+ products that range from creams and capsules to powders, sprays, suspensions and more.

Finished Dosage Formulation

A Finished Dosage Form is a finished drug product resulting from Finished Dosage Formulation (FDF), the various processes involved in production such as manufacturing, testing, and subsequent approval for consumption and delivery to the public.

Active Pharmaceutical Ingredients (API’s), responsible for the results the user gets after taking the dosage forms, are involved in the FDF along with inactive ingredients (excipients) which serve as a medium for the active ingredients to function.

FDF is a critical stage in the product lifecycle and can only be achieved if the manufacturing facility of a pharmaceutical company or Contract Manufacturing Organization is up to a high-end standard. This is a major reason why some companies are into out-licensing since they don’t have the standard manufacturing facility to produce the dosage forms.

Processes Involved in Finished Dosage Formulation Development

The processes involved here are quite complex. Analysis comes first involving the active pharmaceutical ingredients and excipients. A compatibility study is also done between them.

Next is the formulation development which includes the definition of quantitative and qualitative formulas, formulating the manufacturing method, and establishment of in-process controls.

The next process is the main manufacturing process, which then proceeds to quality control, clinical trials, stability studies and manufacturing regulations before the drug product is transferred to the client if it’s been conducted by a pharmaceutical contract manufacturing organization.

What are the Benefits of Outsourcing Finished Dosage Formulation Development?

Formulation development is an integral process for any commercial manufacturing pharma company and even for private purposes in the development of solid dosage forms. This is why outsourcing always comes in handy because the pharmaceutical contract manufacturing firms are usually more equipped with state-of-the-art manufacturing equipment.

They also ensure that the drug product meets the required industry benchmark using the right method development and standard clinical trial materials to ensure there are no loopholes.

Overall, outsourcing ensures that the dosage form is up to the best standard and is duly regulated.

Growth in Finished Dosage Formulations Market

The key factors that are driving trends in the finished dosage formulation market are:

• Access to cutting-edge technological resources in the global pharmaceutical industry.

• An increased need to outsource drug development and pharmaceutical contract manufacturing.

• The increasing contract manufacturing market share of the industry.



Laws and Regulations for the Manufacture of Finished Dosage Formulation

The US FDA’s Current Good Manufacturing Practice regulations require three successful full-scale batches of finished dosage formulation. These three validation batches are essential to ensure that process design and development studies are up to the required standard for active pharmaceutical ingredients, excipients, and drug production generally. GMP compliance is vital to acquire a license to manufacture finished dosage formulations like soft gelatin capsules.



References

Upcoming Events

  • CPHI Korea 2026

    COEX, Seoul, Korea
    25 Aug 2026 - 27 Aug 2026
  • CPHI & PMEC Shenzhen 2026

    Shenzhen Convention & Exhibition Center (SZCEC), China
    16 Sep 2026 - 18 Sep 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026

Pharmaceutical Industry Webinars